首页|西藏地区藏族人群垂体神经内分泌肿瘤/垂体腺瘤临床病理观察

西藏地区藏族人群垂体神经内分泌肿瘤/垂体腺瘤临床病理观察

扫码查看
目的 探讨西藏地区藏族人群垂体神经内分泌肿瘤/垂体腺瘤(PitNET/PA)病例的临床病理特征.方法 回顾性分析2013-10-2021-03间西藏自治区人民医院病理科存档的藏族患者垂体神经内分泌肿瘤/垂体腺瘤(PitNET/PA)病例38例,收集患者临床及病理资料,并进行垂体转录因子及垂体激素等相关免疫组织化学染色,观察临床病理相关性.结果38例病例,年龄22~73岁,男女比例10∶9.患者术前影像学资料显示巨大肿瘤7例(18.42%),大肿瘤31例(81.58%),无微小肿瘤.根据最新分类方法:PIT-1谱系肿瘤13例,T-PIT谱系肿瘤2例,SF-1谱系肿瘤20例,未明确谱系肿瘤3例;其中高风险肿瘤8例(21.05%).10例(26.32%)患者术后肿瘤复发.结论 西藏地区藏族人群垂体神经内分泌肿瘤/垂体腺瘤(PitNET/PA)患者,有较高的高风险类型及巨大肿瘤出现率和术后复发率,提示高原地区藏族患者的肿瘤预后需要更积极的干预措施.
Clinicopathological features of pituitary neuroendocrine tumor/pituitary adenoma in Tibetan population in Tibet
Objective To investigate the clinicopathological features of PitNET/PA cases in Tibetan population in Tibet.Methods A total of 38 cases of Tibetan pituitary neuroendocrine tumor/pituitary adenoma(PitNET/PA)were collected from October 2013 to March 2021 in the Department of Pathology,People's Hospital of Tibet Autonomous Region.The clinical and pathological data were collected,and immunohistochemical staining of pituitary transcription factors and pituitary hormones was performed to observe the clinicopathological correlation.Results The age of the patients ranged from 22 to 73 years,and the ratio of male to female was 10∶9.Preoperative imaging data showed 7 cases(18.42%)of giant tumors,31 cases(81.58%)of large tumors,and no small tumors.According to the latest WHO classification,there were 13 cases of PIT-1 lineage tumor,2 cases of T-PIT lineage tumor,20 cases of SF-1 lineage tumor,and 3 cases of PitNETs with no distinct cell lineage.Among them,8 cases(21.05%)were high-risk tumors.Ten cases(26.32%)had tumor recurrence after operation.Conclusion Tibetan patients with PitNET/PA in Tibet have higher high-risk types,giant tumors and postoperative recurrence rates,suggesting that more active intervention measures are needed for the prognosis of tumors in Tibetan patients in plateau areas.

Tibet regionTibetansPituitary neuroendocrine tumorTranscription factor

多布啦、赵大春、罗含欢、霍真

展开 >

西藏自治区人民医院病理科,拉萨 850000

中国医学科学院北京协和医院病理科,北京 100730

西藏地区 藏族 垂体神经内分泌肿瘤 转录因子

2024

诊断病理学杂志
北京军区总医院

诊断病理学杂志

CSTPCD
影响因子:0.663
ISSN:1007-8096
年,卷(期):2024.31(1)
  • 14